Serum Institute deploys first doses of Oxford, Novavax-partnered malaria shot to Africa
Serum Institute deploys first doses of Oxford, Novavax-partnered malaria shot to Africa fkansteiner Mon, 05/20/2024 - 16:00
Serum Institute deploys first doses of Oxford, Novavax-partnered malaria shot to Africa fkansteiner Mon, 05/20/2024 - 16:00
Sanofi and Regeneron update trial data, strengthening case for Dupixent in COPD kdunleavy Mon, 05/20/2024 - 13:59
As Stelara nears patent cliff, J&J fortifies Tremfya for upcoming ulcerative colitis showdown aliu Mon, 05/20/2024 - 11:00
Pfizer unit wins $107.5M verdict in cancer-drug patent case against AstraZeneca zbecker Mon, 05/20/2024 - 10:36
AstraZeneca places $1.5B bet on end-to-end ADC manufacturing in Singapore fkansteiner Mon, 05/20/2024 - 09:18
Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD kdunleavy Mon, 05/20/2024 - 09:12
3rd time's the charm? PTC will get another chance to keep Translarna's European marketing authorization esagonowsky Mon, 05/20/2024 - 08:45